Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms
Comparative Study of the Efficacy and Safety Outcomes of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neuroendocrine Tumors
2 other identifiers
interventional
156
1 country
1
Brief Summary
To determine the efficacy and safety of robotic, laparoscopic and open surgery for enucleation of benign pancreatic neuroendocrine tumors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 26, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedAugust 6, 2015
August 1, 2015
8 months
April 26, 2014
August 4, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Pancreatic fistula rate
up to 30 days
Secondary Outcomes (1)
Mortality rate
up to 30 days
Other Outcomes (8)
Intra-operative bleeding volume
intra operative
Operation Time
Intra operative
Conversion rate to open surgery
Intra operative
- +5 more other outcomes
Study Arms (3)
robotic arm
EXPERIMENTALrobotic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50
Laparoscopic surgery
EXPERIMENTALlaparoscopic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50
Open surgery
EXPERIMENTALOpen surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 100
Interventions
Robotic surgery: enucleation benign Pancreatic Neuroendocrine Tumors
Laparoscopic surgery: enucleation benign Pancreatic Neuroendocrine Tumors
Eligibility Criteria
You may qualify if:
- years old
- Body Mass Index\<30
- Preoperative diagnosis of resectable benign Pancreatic Neuroendocrine Tumors
- Tumor type: Non-functional pancreatic endocrine tumours and insulinomas
- largest diameter \< 4cm
- Preoperative CT showed no evidence that tumor was connected with main pancreatic duct
You may not qualify if:
- Severe cardio/pulmonary complications
- Other pancreatic diseases, including pancreatitis and pancreatic cancer
- Multiple pancreatic neuroendocrine tumors
- Distant metastasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General Surgery, Peking Union medical school hospital
Beijing, Beijing Municipality, 100730, China
Related Publications (1)
Tian F, Hong XF, Wu WM, Han XL, Wang MY, Cong L, Dai MH, Liao Q, Zhang TP, Zhao YP. Propensity score-matched analysis of robotic versus open surgical enucleation for small pancreatic neuroendocrine tumours. Br J Surg. 2016 Sep;103(10):1358-64. doi: 10.1002/bjs.10220. Epub 2016 Aug 2.
PMID: 27480993DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yupei Zhao, MD
Peking Union Medical College Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2014
First Posted
April 29, 2014
Study Start
April 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
August 6, 2015
Record last verified: 2015-08